US RESEARCHERS at New York’s
Cold Spring Harbor Laboratory have
discovered the protein that helps
spreads ovarian cancer, bringing
new hope that more women with
the disease can be protected.
Two thirds of women are not
diagnosed with the disease until
stage 3 or later, by which time it is
very difficult to manage, with less
than 30% of women surviving.
The survival rate in Australia is
around 43% and there were more
than 900 deaths caused by ovarian
cancer in 2013, the report said.
The target protein FER is now the
focus of future research, according
to the study report published in the
Genes & Development journal.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jul 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jul 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.